These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7031084)

  • 1. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM; Elliott LH; Heymann DL
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS; van der Groen G
    Vopr Virusol; 1985; 30(5):624-6. PubMed ID: 3907144
    [No Abstract]   [Full Text] [Related]  

  • 4. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.
    van der Groen G; Kurata T; Mets C
    Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC; Fontenille D; Georges AJ; Coulanges P
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hemorrhagic fever antibodies in Nigerian populations.
    Tomori O; Fabiyi A; Sorungbe A; Smith A; McCormick JB
    Am J Trop Med Hyg; 1988 Mar; 38(2):407-10. PubMed ID: 3128130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK
    Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research with the Marburg, Lassa and Ebola viruses].
    Pshenichnov VA; Makhlaĭ AA; Mikhaĭlov VV
    Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N
    Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of cross reactivity of rhabdovirus antibodies with Marburg and Ebola antigens in the indirect immunofluorescent antibody test.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):67-8. PubMed ID: 6179483
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates.
    Johnson BK; Gitau LG; Gichogo A; Tukei PM; Else JG; Suleman MA; Kimani R; Sayer PD
    Trans R Soc Trop Med Hyg; 1982; 76(3):307-10. PubMed ID: 6810518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Marburg, Lassa and Ebola virus as cause of hemorrhagic fever].
    Siegert R
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1176-81. PubMed ID: 352653
    [No Abstract]   [Full Text] [Related]  

  • 15. [Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].
    Nakounné E; Selekon B; Morvan J
    Bull Soc Pathol Exot; 2000 Jan; 93(5):340-7. PubMed ID: 11775321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren.
    Blackburn NK; Searle L; Taylor P
    Trans R Soc Trop Med Hyg; 1982; 76(6):803-5. PubMed ID: 6761909
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecology of ebola virus: a first clue?
    Johnson KM; Scribner CL; McCormick JB
    J Infect Dis; 1981 May; 143(5):749-51. PubMed ID: 7017023
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H
    Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.
    Gonzalez JP; Josse R; Johnson ED; Merlin M; Georges AJ; Abandja J; Danyod M; Delaporte E; Dupont A; Ghogomu A
    Res Virol; 1989; 140(4):319-31. PubMed ID: 2505350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.